Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3753-3763

  Sjöstrand, Maria ^a   Ambrosi, Aurélie ^a   Brauner, Susanna ^a   Sullivan, Jenna ^b   Malin, Stephen ^a   Kuchroo, Vijay K ^b   Espinosa, Alexander ^a,c   Wahren Herlenius, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYCLOHEXIMIDE; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 4; STAT1 PROTEIN; TRIPARTITE MOTIF 21 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERFERON STIMULATED RESPONSE ELEMENT; MACROPHAGE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; SJOEGREN SYNDROME; T LYMPHOCYTE; TRANSCRIPTION INITIATION SITE;

ANIMALS; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION; GENE ORDER; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME; STAT1 TRANSCRIPTION FACTOR;

EID: 84885124689     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202341     Document Type: Article

References (63)

1. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, et al. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-2151.
2. Zheng, N., P. Wang, P. D. Jeffrey, and N. P. Pavletich. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102:533-539.
3. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309-312.
4. Peng, H., G. E. Begg, D. C. Schultz, J. R. Friedman, D. E. Jensen, D. W. Speicher, and F. J. Rauscher, III. 2000. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J. Mol. Biol. 295:1139-1162.
5. Napolitano, L. M., and G. Meroni. 2012. TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life 64:64-71.
6. Pertel, T., S. Hausmann, D. Morger, S. Züger, J. Guerra, J. Lascano, C. Reinhard, F. A. Santoni, P. D. Uchil, L. Chatel, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365.
7. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
8. Yoshimi, R., T. H. Chang, H. Wang, T. Atsumi, H. C. Morse, III, and K. Ozato. 2009. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-κB-dependent cytokine expression in fibroblasts. J. Immunol. 182:7527-7538.
9. Espinosa, A., V. Dardalhon, S. Brauner, A. Ambrosi, R. Higgs, F. J. Quintana, M. Sjöstrand, M. L. Eloranta, J. Ní Gabhann, O. Winqvist, et al. 2009. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 206:1661-1671.
10. Barr, S. D., J. R. Smiley, and F. D. Bushman. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4:e1000007.
11. Gack, M. U., R. A. Albrecht, T. Urano, K. S. Inn, I. C. Huang, E. Carnero, M. Farzan, S. Inoue, J. U. Jung, and A. García-Sastre. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449.
12. Gack, M. U., Y. C. Shin, C. H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
13. Ozato, K., D. M. Shin, T. H. Chang, and H. C. Morse, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
14. Nisole, S., J. P. Stoye, and A. Säib. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808.
15. Kong, H. J., D. E. Anderson, C. H. Lee, M. K. Jang, T. Tamura, P. Tailor, H. K. Cho, J. Cheong, H. Xiong, H. C. Morse, III, and K. Ozato. 2007. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179:26-30.
16. Higgs, R., J. Ní Gabhann, N. Ben Larbi, E. P. Breen, K. A. Fitzgerald, and C. A. Jefferies. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-b production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181:1780-1786.
17. Higgs, R., E. Lazzari, C. Wynne, J. Ní Gabhann, A. Espinosa, M. Wahren-Herlenius, and C. A. Jefferies. 2010. Self protection from anti-viral responses-Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors. PLoS One 5:e11776.
18. Yang, K., H. X. Shi, X. Y. Liu, Y. F. Shan, B. Wei, S. Chen, and C. Wang. 2009. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J. Immunol. 182:3782-3792.
19. Zhang, Z., M. Bao, N. Lu, L. Weng, B. Yuan, and Y. J. Liu. 2013. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 14:172-178.
20. Carthagena, L., A. Bergamaschi, J. M. Luna, A. David, P. D. Uchil, F. Margottin-Goguet, W. Mothes, U. Hazan, C. Transy, G. Pancino, and S. Nisole. 2009. Human TRIM gene expression in response to interferons. PLoS One 4:e4894.
21. Rajsbaum, R., J. P. Stoye, and A. O'Garra. 2008. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38:619-630.
22. Lyons, P. A., E. F. McKinney, T. F. Rayner, A. Hatton, H. B. Woffendin, M. Koukoulaki, T. C. Freeman, D. R. Jayne, A. N. Chaudhry, and K. G. Smith. 2010. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 69:1208-1213.
23. Oke, V., I. Vassilaki, A. Espinosa, L. Strandberg, V. K. Kuchroo, F. Nyberg, and M. Wahren-Herlenius. 2009. High Ro52 expression in spontaneous and UV-induced cutaneous inflammation. J. Invest. Dermatol. 129:2000-2010.
24. Espinosa, A., W. Zhou, M. Ek, M. Hedlund, S. Brauner, K. Popovic, L. Horvath, T. Wallerskog, M. Oukka, F. Nyberg, et al. 2006. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J. Immunol. 176:6277-6285.
25. van Boxel-Dezaire, A. H., M. R. Rani, and G. R. Stark. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361-372.
26. Hervas-Stubbs, S., J. L. Perez-Gracia, A. Rouzaut, M. F. Sanmamed, A. Le Bon, and I. Melero. 2011. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 17:2619-2627.
27. Porter, A. C., Y. Chernajovsky, T. C. Dale, C. S. Gilbert, G. R. Stark, and I. M. Kerr. 1988. Interferon response element of the human gene 6-16. EMBO J. 7:85-92.
28. Friedman, R. L., and G. R. Stark. 1985. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637-639.
29. Pine, R., and J. E. Darnell, Jr. 1989. In vivo evidence of interaction between interferon-stimulated gene factors and the interferon-stimulated response element. Mol. Cell. Biol. 9:3533-3537.
30. Yuan, J., U. M. Wegenka, C. Lütticken, J. Buschmann, T. Decker, C. Schindler, P. C. Heinrich, and F. Horn. 1994. The signalling pathways of interleukin-6 and g interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol. Cell. Biol. 14:1657-1668.
31. Rein, T., M. Müller, and H. Zorbas. 1994. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res. 22:3033-3037.
32. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene regulatory elements. Cell 54:903-913.
33. Pine, R., T. Decker, D. S. Kessler, D. E. Levy, and J. E. Darnell, Jr. 1990. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both b interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10:2448-2457.
34. Decker, T., D. J. Lew, J. Mirkovitch, and J. E. Darnell, Jr. 1991. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J. 10:927-932.
35. Lew, D. J., T. Decker, and J. E. Darnell, Jr. 1989. Alpha interferon and g interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. Cell. Biol. 9:5404-5411.
36. Shuai, K., C. Schindler, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Activation of transcription by IFN-g: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-1812.
37. Feng, X., H. Wu, J. M. Grossman, P. Hanvivadhanakul, J. D. FitzGerald, G. S. Park, X. Dong, W. Chen, M. H. Kim, H. H. Weng, et al. 2006. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 54:2951-2962.
38. Ebert, A., S. McManus, H. Tagoh, J. Medvedovic, G. Salvagiotto, M. Novatchkova, I. Tamir, A. Sommer, M. Jaritz, and M. Busslinger. 2011. The distal V (H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells. Immunity 34:175-187.
39. Lin, Y. C., S. Jhunjhunwala, C. Benner, S. Heinz, E. Welinder, R. Mansson, M. Sigvardsson, J. Hagman, C. A. Espinoza, J. Dutkowski, et al. 2010. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 11:635-643.
40. Nicol, J. W., G. A. Helt, S. G. Blanchard, Jr., A. Raja, and A. E. Loraine. 2009. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 25:2730-2731.
41. Rhodes, D. A., G. Ihrke, A. T. Reinicke, G. Malcherek, M. Towey, D. A. Isenberg, and J. Trowsdale. 2002. The 52000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferongamma inducible tripartite motif protein associated with membrane proximal structures. Immunology 106:246-256.
42. Strandberg, L., A. Ambrosi, A. Espinosa, L. Ottosson, M. L. Eloranta, W. Zhou, A. Elfving, E. Greenfield, V. K. Kuchroo, and M. Wahren-Herlenius. 2008. Interferon-a induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J. Clin. Immunol. 28:220-231.
43. Abramovich, C., L. M. Shulman, E. Ratovitski, S. Harroch, M. Tovey, P. Eid, and M. Revel. 1994. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-a and IFN-b. EMBO J. 13:5871-5877.
44. Croze, E., D. Russell-Harde, T. C. Wagner, H. Pu, L. M. Pfeffer, and H. D. Perez. 1996. The human type I interferon receptor: identification of the interferon b-specific receptor-associated phosphoprotein. J. Biol. Chem. 271:33165-33168.
45. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
46. Oshima, S., T. Nakamura, S. Namiki, E. Okada, K. Tsuchiya, R. Okamoto, M. Yamazaki, T. Yokota, M. Aida, Y. Yamaguchi, et al. 2004. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells. Mol. Cell. Biol. 24:6298-6310.
47. Meraro, D., S. Hashmueli, B. Koren, A. Azriel, A. Oumard, S. Kirchhoff, H. Hauser, S. Nagulapalli, M. L. Atchison, and B. Z. Levi. 1999. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163:6468-6478.
48. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100:2610-2615.
49. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-723.
50. Mavragani, C. P., and M. K. Crow. 2010. Activation of the type I interferon pathway in primary Sjogren's syndrome. J. Autoimmun. 35:225-231.
51. Starr, R., and D. J. Hilton. 1999. Negative regulation of the JAK/STAT pathway. Bioessays 21:47-52.
52. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535-584.
53. Honda, K., and T. Taniguchi. 2006. Toll-like receptor signaling and IRF transcription factors. IUBMB Life 58:290-295.
54. Nakagawa, K., and H. Yokosawa. 2000. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway: the C-terminal region governs the protein stability. Eur. J. Biochem. 267:1680-1686.
55. Han, K. J., L. Jiang, and H. B. Shu. 2008. Regulation of IRF2 transcriptional activity by its sumoylation. Biochem. Biophys. Res. Commun. 372:772-778.
56. Nakagawa, K., and H. Yokosawa. 2002. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 530:204-208.
57. 1/S transition in the prolactin-induced lymphocyte cell cycle. Mol. Endocrinol. 6:2236-2243.
58. Watanabe, N., J. Sakakibara, A. G. Hovanessian, T. Taniguchi, and T. Fujita. 1991. Activation of IFN-β element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19:4421-4428.
59. Pernis, A. B. 2002. The role of IRF-4 in B and T cell activation and differentiation. J. Interferon Cytokine Res. 22:111-120.
60. Ishii, T., K. Ohnuma, A. Murakami, N. Takasawa, T. Yamochi, S. Iwata, M. Uchiyama, N. H. Dang, H. Tanaka, and C. Morimoto. 2003. SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J. Immunol. 170:3653-3661.
61. Fang, T. C., U. Schaefer, I. Mecklenbrauker, A. Stienen, S. Dewell, M. S. Chen, I. Rioja, V. Parravicini, R. K. Prinjha, R. Chandwani, et al. 2012. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J. Exp. Med. 209:661-669.
62. Fujii, Y., T. Shimizu, M. Kusumoto, Y. Kyogoku, T. Taniguchi, and T. Hakoshima. 1999. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 18:5028-5041.
63. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.